Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease
暂无分享,去创建一个
Y. Eguchi | A. Nakajima | R. Loomba | H. Suganami | M. Yoneda | K. Imajo | N. Tamaki | T. Nojima | Ryohei Tanigawa | Masakazu Iizuka | Yuki Iida | Kento Imajo | Yuichiro Eguchi